-
Loading metrics
An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies
- Alexandre Perrier,
- Pierre-Yves Boelle,
- Yves Chrétien,
- Joseph Gligorov,
- Jean-Pierre Lotz,
- Didier Brault,
- Eva Comperat,
- Guillaume Lefèvre,
- Mathieu Boissan
x
- Published: January 7, 2020
- https://doi.org/10.1371/journal.pone.0227356